Litcius/Paper detail

Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach

Swati Singh, Hemanth Naick Banavath, Priya Godara, Biswajit Naik, Varshita Srivastava, Dhaneswar Prusty

20223 Biotech22 citationsDOIOpen Access PDF

Topics & Concepts

PeptideChemistryIn silicoDocking (animal)InfectivitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Molecular dynamicsReceptorCoronavirus disease 2019 (COVID-19)Computational biologyBiochemistryBiologyVirologyVirusGeneDiseaseMedicineNursingComputational chemistryInfectious disease (medical specialty)PathologySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesDermatological and COVID-19 studies
Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach | Litcius